Vaccinogen Inc.

Vaccinogen Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$3.73 M
Shares Outstanding
37.32 M
Public Float
-

Profile

Address
949 Fell Street
Baltimore Maryland 21231
United States
Employees -
Website http://www.vaccinogeninc.com
Updated 09/14/2018
Vaccinogen, Inc. is an immunotherapy company. The company engages in the development and commercialization of vaccines and immunotherapeutic products for cancer. Its primary product, OncoVAX is a vaccine for post-surgical treatment of stage II colon cancer.

Financials

View All

Andrew L. Tussing
Chairman, President & Chief Executive Officer
Michael G. Hanna
Chairman-Emeritus